Fellowship ​

Professor Jonathan Kalman is an NHMRC practitioner fellow who leads both clinical and research groups in the Department of Cardiac Arrhythmias at the Royal Melbourne Hospital and University of Melbourne. He has a national and international reputation as a leader in the field of atrial arrhythmias and has authored over 300 peer-reviewed publications (H Index 74, over 27,700 citations), more than 40 book chapters and delivered over 200 invited lectures at national and international meetings. His areas of research interest include the mechanisms, treatment and prevention of atrial arrhythmias. His work has repeatedly influenced clinical guidelines and consensus documents.

Professor Jandeleit-Dahm is a clinician scientist (FRACP) and NHMRC Senior Research fellow with an established track record in diabetes and its complications. She is considered a national and international leader in diabetes research and has made seminal discoveries on new targets to treat diabetic complications. She has been successful in obtaining ongoing grant funding. Currently, Professor Jandeleit-Dahm is Deputy Head of the Department of Diabetes at Monash University. She has over 150 highly cited publications. She holds two Professorships at Monash University and the University of Hannover, Germany, and leadership positions in education, research and health policies. She was the President of the Australian Atherosclerosis Society 2010-2014. She is committed to advancing medical and health science as evidenced by her ongoing involvement in peer review (NHMRC, JDRF), editorial roles and advisory board commitments.

Professor Hellard is an infectious disease physician, public health physician and researcher; she is recognised as a global leader in epidemiology and clinical care especially in the fields of hepatitis C and HIV among key populations, and for using new technologies in health promotion. Her work has directly informed policy direction and practice in Australia and globally. Her research experience, paired with her clinical and public health expertise has led to roles on numerous national and international advisory committees, taskforces and working groups, including being current co-Chair of the WHO Strategic and Technical Advisory Committee on HIV and Viral Hepatitis.

Professor Grimmond is internationally recognised as a leader in cancer genomics, a pioneer of transcriptomics, and a committed advocate to genome-directed medicine. Over the last 25 years he has led a broad research program which uses transcriptome dynamics and genome content to uncover the underlying genetics controlling malignancies, developmental defects and pluripotency. Since 2009, Professor Grimmond has led Australia’s contribution to the International Cancer Genome Consortium and resolved the root causes, driving mutations and potential therapeutic targets present in some of our most challenging malignancies including pancreatic, melanoma, ovarian, neuroendocrine, and oesophageal cancers.

Professor Fairley has substantially improved sexual health services over many years. He was the first to recognise that access to health care was the key driver of sexually transmitted infections (STI) in Indigenous communities (Hansard 1997). He has led innovations in sexual health services in Australia and internationally that have materially improved access to services including ‘virtual’ services for notifying sexual partners and remote testing, and most recently a web site that diagnoses STls using a Bayesian mathematical algorithm. Currently he is working on a new paradigm for the transmission of gonorrhoea that may provide a condomless control intervention (using mouthwash).

Professor Degli-Esposti is an eminent researcher of international standing and a leader in the field of viral immunology. She has made multiple seminal contributions to understanding the immunological pathways invoked in response to viral infection and the pathophysiology of the resulting disease. Her work has been the subject of highly cited papers in prestigious journals and she is regularly invited to speak at premier international conferences. Insights from her studies are guiding the improved management of chronic viral infections and their complications, including the development of autoimmunity and transplant-related disease. Professor Degli-Esposti also plays a major service and leadership role.